共 50 条
- [8] Sorafenib in Patients With Metastatic Renal Cell Carcinoma Refractory to Either Sunitinib or Bevacizumab Editorial Comment JOURNAL OF UROLOGY, 2011, 185 (03): : 809 - 809
- [9] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment JOURNAL OF UROLOGY, 2010, 184 (04): : 1303 - 1303